Literature DB >> 7957075

Pulvomycin-resistant mutants of E.coli elongation factor Tu.

L A Zeef1, L Bosch, P H Anborgh, R Cetin, A Parmeggiani, R Hilgenfeld.   

Abstract

This paper reports the generation of Escherichia coli mutants resistant to pulvomycin. Together with targeted mutagenesis of the tufA gene, conditions were found to overcome membrane impermeability, thereby allowing the selection of three mutants harbouring elongation factor (EF)-Tu Arg230-->Cys, Arg333-->Cys or Thr334-->Ala which confer pulvomycin resistance. These mutations are clustered in the three-domain junction interface of the crystal structure of the GTP form of Thermus thermophilus EF-Tu. This result shares similarities with kirromycin resistance; kirromycin-resistant mutations cluster in the domain 1-3 interface. Since both interface regions are involved in the EF-Tu switch mechanism, we propose that pulvomycin and kirromycin both act by specifically disturbing the allosteric changes required for the switch from EF-Tu-GTP to EF-Tu-GDP. The three-domain junction changes dramatically in the switch to EF-Tu.GDP; in EF-Tu.GDP this region forms an open hole. Structural analysis of the mutation positions in EF-Tu.GTP indicated that the two most highly resistant mutants, R230C and R333C, are part of an electrostatic network involving numerous residues. All three mutations appear to destabilize the EF-Tu.GTP conformation. Genetic and protein characterizations show that sensitivity to pulvomycin is dominant over resistance. This appears to contradict the currently accepted model of protein synthesis inhibition by pulvomycin.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7957075      PMCID: PMC395458          DOI: 10.1002/j.1460-2075.1994.tb06840.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  38 in total

1.  ILOLATION AND CHARACTERIZATION OF LABILOMYCIN, A NEW ANTIBIOTIC.

Authors:  E AKITA; K MAEDA; H UMEZAWA
Journal:  J Antibiot (Tokyo)       Date:  1963-07       Impact factor: 2.649

2.  CHEMISTRY OF LABILOMYCIN.

Authors:  E AKITA; K MAEDA; H UMEZAWA
Journal:  J Antibiot (Tokyo)       Date:  1964-09       Impact factor: 2.649

3.  Effect of kirromycin on elongation factor Tu. Location of the catalytic center for ribosome-elongation-factor-Tu GTPase activity on the elongation factor.

Authors:  G Chinali; H Wolf; A Parmeggiani
Journal:  Eur J Biochem       Date:  1977-05-02

4.  Mechanism of the inhibition of protein synthesis by kirromycin. Role of elongation factor Tu and ribosomes.

Authors:  H Wolf; G Chinali; A Parmeggiani
Journal:  Eur J Biochem       Date:  1977-05-02

5.  Growth and translation elongation rate are sensitive to the concentration of EF-Tu.

Authors:  I Tubulekas; D Hughes
Journal:  Mol Microbiol       Date:  1993-05       Impact factor: 3.501

6.  The crystal structure of elongation factor EF-Tu from Thermus aquaticus in the GTP conformation.

Authors:  M Kjeldgaard; P Nissen; S Thirup; J Nyborg
Journal:  Structure       Date:  1993-09-15       Impact factor: 5.006

Review 7.  Harnessing the writhe: a role for DNA chaperones in nucleoprotein-complex formation.

Authors:  S S Ner; A A Travers; M E Churchill
Journal:  Trends Biochem Sci       Date:  1994-05       Impact factor: 13.807

8.  Site-directed mutagenesis of elongation factor Tu. The functional and structural role of residue Cys81.

Authors:  P H Anborgh; A Parmeggiani; J Jonák
Journal:  Eur J Biochem       Date:  1992-09-01

9.  Ternary complex formation between elongation factor Tu, GTP and aminoacyl-tRNA: an equilibrium study.

Authors:  A Pingoud; C Urbanke; G Krauss; F Peters; G Maass
Journal:  Eur J Biochem       Date:  1977-09

10.  The structural and functional basis for the kirromycin resistance of mutant EF-Tu species in Escherichia coli.

Authors:  J R Mesters; L A Zeef; R Hilgenfeld; J M de Graaf; B Kraal; L Bosch
Journal:  EMBO J       Date:  1994-10-17       Impact factor: 11.598

View more
  6 in total

Review 1.  Elfamycins: inhibitors of elongation factor-Tu.

Authors:  Samantha M Prezioso; Nicole E Brown; Joanna B Goldberg
Journal:  Mol Microbiol       Date:  2017-08-09       Impact factor: 3.501

Review 2.  Throwing a spanner in the works: antibiotics and the translation apparatus.

Authors:  C M Spahn; C D Prescott
Journal:  J Mol Med (Berl)       Date:  1996-08       Impact factor: 4.599

3.  Elongation factor Tu3 (EF-Tu3) from the kirromycin producer Streptomyces ramocissimus Is resistant to three classes of EF-Tu-specific inhibitors.

Authors:  Lian N Olsthoorn-Tieleman; Robert-Jan T S Palstra; Gilles P van Wezel; Mervyn J Bibb; Cornelis W A Pleij
Journal:  J Bacteriol       Date:  2007-03-02       Impact factor: 3.490

4.  Enacyloxin IIa, an inhibitor of protein biosynthesis that acts on elongation factor Tu and the ribosome.

Authors:  R Cetin; I M Krab; P H Anborgh; R H Cool; T Watanabe; T Sugiyama; K Izaki; A Parmeggiani
Journal:  EMBO J       Date:  1996-05-15       Impact factor: 11.598

5.  Comparative Genomics Analyses Support the Reclassification of Bisgaard Taxon 40 as Mergibacter gen. nov., With Mergibacter septicus sp. nov. as Type Species: Novel Insights Into the Phylogeny and Virulence Factors of a Pasteurellaceae Family Member Associated With Mortality Events in Seabirds.

Authors:  Eliana De Luca; Sonsiray Álvarez-Narváez; Grazieli Maboni; Rodrigo P Baptista; Nicole M Nemeth; Kevin D Niedringhaus; Jason T Ladner; Jeffrey M Lorch; Galina Koroleva; Sean Lovett; Gustavo F Palacios; Susan Sanchez
Journal:  Front Microbiol       Date:  2021-11-22       Impact factor: 5.640

6.  Detection of antimicrobial resistance genes in urban air.

Authors:  Ágnes Becsei; Norbert Solymosi; István Csabai; Donát Magyar
Journal:  Microbiologyopen       Date:  2021-11       Impact factor: 3.139

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.